These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29188815)

  • 1. Inflammation: Association between hsCRP reduction and cardiac outcomes.
    Huynh K
    Nat Rev Cardiol; 2018 Jan; 15(1):2-3. PubMed ID: 29188815
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
    Ridker PM; MacFadyen JG; Everett BM; Libby P; Thuren T; Glynn RJ;
    Lancet; 2018 Jan; 391(10118):319-328. PubMed ID: 29146124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and Cholesterol Risk in the FOURIER Trial.
    Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
    Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Inflammation in Cardiovascular Disease.
    Martinez BK; White CM
    Ann Pharmacother; 2018 Aug; 52(8):801-809. PubMed ID: 29557210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus.
    Pfützner A; Forst T
    Diabetes Technol Ther; 2006 Feb; 8(1):28-36. PubMed ID: 16472048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3.
    Egeberg A; Wu JJ; Korman N; Solomon JA; Goldblum O; Zhao F; Mallbris L
    J Am Acad Dermatol; 2018 Jul; 79(1):104-109.e8. PubMed ID: 29548945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
    Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic low-grade inflammation, lipid risk factors and mortality in functionally dependent elderly].
    Vasović O; Trifunović D; Despotovié N; Milosević DP
    Vojnosanit Pregl; 2010 Jul; 67(7):562-8. PubMed ID: 20707051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective.
    Kamath DY; Xavier D; Sigamani A; Pais P
    Indian J Med Res; 2015 Sep; 142(3):261-8. PubMed ID: 26458341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk assessment using high-sensitivity C-reactive protein in patients with erectile dysfunction.
    Ferrandis-Cortes C; Martínez-Jabaloyas JM; Díez-Calzadilla NA; Hernández-Medina JA; Chuan-Nuez P
    Urol Int; 2013; 91(2):187-91. PubMed ID: 23816857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in U.S. adults.
    Mazidi M; Kengne AP; Mikhailidis DP; Cicero AF; Banach M
    Ann Med; 2018 Feb; 50(1):1-6. PubMed ID: 28462631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein: clinical importance.
    Bassuk SS; Rifai N; Ridker PM
    Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Yang SJ; Kim S; Choi HY; Kim TN; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Int J Cardiol; 2013 Mar; 163(3):277-281. PubMed ID: 21719129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents].
    Shu Y; He S; Chen XP; Lü ZB; Yang R; Liu K; Cui KJ; Huang DJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):125-30. PubMed ID: 22490712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.
    Jialal I; Devaraj S
    Am J Clin Pathol; 2001 Dec; 116 Suppl():S108-15. PubMed ID: 11993695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET.
    Yoo HJ; Kim S; Park MS; Yang SJ; Kim TN; Seo JA; Kim SG; Kim NH; Seo HS; Baik SH; Choi DS; Choi KM
    J Nucl Med; 2011 Jan; 52(1):10-7. PubMed ID: 21149476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease. Massive trials to test inflammation hypothesis.
    Couzin-Frankel J
    Science; 2012 Sep; 337(6099):1158. PubMed ID: 22955810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.